PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Concept Life Sciences strengthens Analytical Services business with three senior appointments

Michelle Gale joins as Head of Customer Services, Dr Ben Cliff as Vice President of Operations, and Lorraine Bater as Regional Director of the South, UK Appointm...
Continue Reading →
News

Recipharm connects to European Hub for serialisation compliance

Recipharm, a leading contract development and manufacturing organisation (CDMO) has successfully received European Medicines Verification Organisation (EMVO) approva...
Continue Reading →
News

PCI and CSP Technologies, Inc. Announce Strategic Collaboration for Breakthrough Activ-BlisterTM Solutions

In scavenging for undesired moisture and gases, protective packaging solution enables enhanced shelf life and speed-to-market for pharmaceutical and medical device p...
Continue Reading →
News

CPhI Annual Report warns trade and patent changes could increase healthcare cost by $100bn over next 5-years

CPhI Annual Report 2018 Part 2: the impact of global regulation and convergence. China is harmonizing to ICH standards at feverish pace and will force poor...
Continue Reading →
News

Systech Announces Partnership with FarmaTrust to Deliver Foolproof Pharmaceutical Blockchain Solution

Ara Ohanian, CEO of Systech Princeton, NJ - London, UK (September 12, 2018) Systech, a global technology leader in brand protection and product authentication, an...
Continue Reading →
News

Novartis’ CAR-T Kymriah gets green light in England

Novartis has set a “fair and affordable” price for its CAR-T therapy Kymriah that should make it available for up to 30 children every year with acute lymphoblastic ...
Continue Reading →
News

Health secretary’s ‘rip off’ remarks anger UK pharma

Claims from new health secretary Matt Hancock that the pharmaceutical industry is trying to “rip off taxpayers” in the UK have shocked the sector. Speaking to T...
Continue Reading →
News

NICE rejects NHS use of Roche’s Ocrevus for PPMS

In its final draft guidance, the UK’s pricing regulator the National Institute of Health and Care Excellence (NICE) has not recommended Roche’s Ocrevus (ocrelizumab)...
Continue Reading →
News

The Scottish Medicines Consortium has cleared funds for use of four new medicines by NHS Scotland, including Sanofi’s biologic Dupixent for dermatitis

Dupixent (dupilumab) is the first biologic drug made available routinely from NHS Scotland for the treatment of moderate to severe atopic dermatitis in adults w...
Continue Reading →
News

EC green-lights MSD’s Keytruda combo for lung cancer

The European Commission has approved MSD’s Keytruda for use in combination with Eli Lilly’s Alimta and platinum-based chemotherapy for the first-line treatment ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026